A provider may monitor: Symptoms and side effects Injection-site reactions Sleep quality Appetite changes Fluid retention Blood pressure Glucose or A1C when appropriate IGF-1 when appropriate Recovery response Whether treatment should continue, pause, or change Monitoring helps prevent patients from guessing, overusing, or continuing therapy when symptoms suggest the plan should be adjusted
Similar results were obtained by Casado-Vela et al
Bianchi, M
Pricing BMI MD publishes four tirzepatide plan lengths, each priced upfront: 12-month plan: $139/mo (total: $1,668) 6-month plan: $149/mo 3-month plan: $159/mo (total: $477) 1-month plan: $179/mo Every plan includes the medication, telehealth visit, prescription, and expedited shipping
The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial